Amgen (AMGN) VP has 68 shares withheld to cover equity award taxes

Rhea-AI Filing Summary

Amgen Inc. vice president, finance and chief accounting officer Matthew C. Busch reported routine share dispositions related to tax withholding. On May 2, 2026, a total of 68 shares of common stock were withheld at $329.82 per share to satisfy tax obligations tied to equity awards.

Following these transactions, Busch directly holds 4,018 shares of Amgen common stock. A footnote explains that his holdings include 49 Dividend Equivalents linked to unvested Restricted Stock Units, which will be settled in common shares as those units vest.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Busch Matthew C.

Role VP, Finance & CAO

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	30	$329.82	$10K
Tax Withholding	Common Stock	38	$329.82	$13K

Holdings After Transaction: Common Stock — 4,018 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Tax-withholding shares: 68 shares First tax-withholding block: 38 shares Second tax-withholding block: 30 shares +3 more

6 metrics

Tax-withholding shares 68 shares Total F-code dispositions on May 2, 2026

First tax-withholding block 38 shares Common Stock, disposition for tax liability

Second tax-withholding block 30 shares Common Stock, disposition for tax liability

Tax-withholding price $329.82 per share Valuation used for both F-code transactions

Shares held after transactions 4,018 shares Direct ownership following May 2, 2026 events

Dividend Equivalents in holdings 49 DEs Credited to unvested RSUs, settle in common stock

Key Terms

tax-withholding disposition, Dividend Equivalents, Restricted Stock Units, Equity Incentive Plan

4 terms

tax-withholding disposition financial

"transaction_action: "tax-withholding disposition" for both Common Stock entries"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Dividend Equivalents financial

"These shares include 49 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended"

Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.

Restricted Stock Units financial

"DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Equity Incentive Plan financial

"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Busch Matthew C.

(Last) (First) (Middle)

ONE AMGEN CENTER DRIVE

(Street)

THOUSAND OAKS CALIFORNIA 91320

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Finance & CAO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/02/2026		F		30	D	$329.82	4,018	D
Common Stock	05/02/2026		F		38	D	$329.82	3,980(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares include 49 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

	/s/ Matthew C. Busch	05/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider activity did Amgen (AMGN) report for Matthew C. Busch?

Amgen reported that VP, Finance & CAO Matthew C. Busch had company shares withheld to cover tax obligations. On May 2, 2026, 68 common shares were disposed of as a tax-withholding transaction rather than an open-market sale, reflecting routine equity compensation mechanics.

How many Amgen shares were withheld for Matthew C. Busch’s taxes?

A total of 68 Amgen common shares were withheld for Matthew C. Busch’s tax obligations. The Form 4 shows two tax-withholding dispositions of 38 shares and 30 shares, both on May 2, 2026, tied to equity compensation events rather than discretionary market selling.

At what price were Matthew C. Busch’s Amgen shares withheld for taxes?

The withheld Amgen shares for Matthew C. Busch’s taxes were valued at $329.82 per share. Both reported tax-withholding transactions on May 2, 2026 used this price, indicating how the number of shares required to satisfy his tax liability was calculated for the equity awards.

How many Amgen shares does Matthew C. Busch hold after these Form 4 transactions?

After the reported tax-withholding transactions, Matthew C. Busch holds 4,018 Amgen common shares directly. This post-transaction balance appears in the Form 4 and shows that only a small portion of his position was used to satisfy related tax obligations from equity compensation.

What are Dividend Equivalents mentioned in Matthew C. Busch’s Amgen filing?

Dividend Equivalents in Busch’s Amgen filing are credits tied to unvested Restricted Stock Units. The footnote notes 49 Dividend Equivalents, which will be paid in Amgen common stock on a one-to-one basis as the RSUs vest, plus cash for any fractional share amounts.

Were Matthew C. Busch’s Amgen transactions open-market sales or tax withholding?

The Form 4 identifies Matthew C. Busch’s Amgen transactions as tax-withholding dispositions, not open-market sales. Code F indicates shares were delivered to cover exercise price or tax liability, meaning these were mechanical transactions linked to equity awards rather than discretionary selling decisions.